Related Experiment Video
Updated: Jul 24, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification.
Caterina Nannelli1,2, Andrea Bosman3, Jane Cunningham3
1University of Florence, Florence, Italy.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is common, but severe chronic anemia is rare. Most G6PD deficient males have residual enzyme activity below 30%, explaining why severe anemia is uncommon.
Area of Science:
- Genetics
- Hematology
- Biochemistry
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked genetic disorder prevalent in many populations, affecting red blood cells.
- This deficiency can lead to acute hemolytic anemia upon exposure to certain triggers like fava beans or drugs, and is a risk factor for neonatal jaundice.
- The World Health Organization (WHO) recommends G6PD testing to guide the administration of 8-aminoquinolines for preventing Plasmodium vivax malaria relapse.
Approach:
- A literature review was conducted to gather G6PD activity data from 2291 males with polymorphic G6PD variants.
- Mean residual red blood cell G6PD activity was estimated for 16 common G6PD deficient variants, revealing a range from 1.9% to 33% of normal activity.
- Analysis explored the relationship between residual G6PD activity and substrate affinity (Km G6P) to understand the biochemical basis of G6PD deficiency variants.
Key Points:
- Most G6PD deficient males exhibit residual enzyme activity below 30% of normal levels, with significant variation across different G6PD variants.
- A direct correlation was observed between residual G6PD activity and substrate affinity (Km G6P), suggesting a protective mechanism against chronic non-spherocytic hemolytic anemia (CNSHA).
- Extensive overlap in G6PD activity values among individuals with different variants and a lack of mean value clustering around 10% support merging WHO G6PD deficiency classes II and III.
Conclusions:
- The study provides reliable estimates for mean residual G6PD activity in common variants, crucial for clinical management and genetic counseling.
- The findings suggest that the biochemical properties of polymorphic G6PD variants, particularly their substrate affinity, play a role in preventing severe chronic hemolytic anemia.
- Consolidating G6PD deficiency classifications based on activity overlap can simplify diagnostic and therapeutic strategies, especially in malaria-endemic regions.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Related Concept Videos
Incomplete Dominance
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Genetic Lingo
Genetic Variation
Genes exist in different versions called alleles,...